Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan M Markarian

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Viruses|September 28, 2021
AMDV Vaccine: Challenges and PerspectivesNathan M Markarian, Levon Abrahamyan
Frontiers in Microbiology|November 18, 2024
The latest advancements in Sosuga virus (SOSV) researchNathan M Markarian, Levon Abrahamyan
Frontiers in Microbiology|July 18, 2022
Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary ImmunodeficiencyNathan M Markarian, Gaël Galli, Dhanesh Patel, et al.
Pathogens (Basel, Switzerland)|October 25, 2024
In Silico Identification of Potential Inhibitors of SARS-CoV-2 Main Protease (M<sup>pro</sup>)Manuel Alejandro Hernández-Serda, Víctor H Vázquez-Valadez, Pablo Aguirre-Vidal, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Viruses|September 28, 2021
AMDV Vaccine: Challenges and PerspectivesNathan M Markarian, Levon Abrahamyan
Frontiers in Microbiology|November 18, 2024
The latest advancements in Sosuga virus (SOSV) researchNathan M Markarian, Levon Abrahamyan
Frontiers in Microbiology|July 18, 2022
Identifying Markers of Emerging SARS-CoV-2 Variants in Patients With Secondary ImmunodeficiencyNathan M Markarian, Gaël Galli, Dhanesh Patel, et al.
Pathogens (Basel, Switzerland)|October 25, 2024
In Silico Identification of Potential Inhibitors of SARS-CoV-2 Main Protease (M<sup>pro</sup>)Manuel Alejandro Hernández-Serda, Víctor H Vázquez-Valadez, Pablo Aguirre-Vidal, et al.
Pageof 1